Search Within

Neil Howard Segal

Formats
  1. Meeting Abstract (110)
  2. Journal Article (95)
  3. Review (2)
  4. Book Section (1)
  5. Miscellaneous (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (210)
  2. Gastrointestinal Oncology Service (210)
  3. Solid Tumor Oncology Division (210)
  4. Center for Pancreatic Cancer Research (97)
  5. Surgery (80)
  6. Survivorship Research (78)

More Groups

People
  1. Leonard Saltz (81)
  2. Andrea Cercek Hanjis (68)
  3. Zsofia Stadler (67)
  4. Martin Weiser (61)
  5. Rona Yaeger (60)
  6. Jinru Shia (55)

More People

Years
  1. 2025 (6)
  2. 2024 (15)
  3. 2023 (12)
  4. 2022 (14)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (78)
  2. Annals of Oncology (21)
  3. Clinical Cancer Research (9)
  4. Cancer Research (6)
  5. Journal for ImmunoTherapy of Cancer (6)
  6. Modern Pathology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Oxford University Press (26)
  3. American Association for Cancer Research (21)
  4. Elsevier Inc. (19)
  5. Nature Publishing Group (10)
  6. Biomed Central Ltd (6)

More Publishers

Results (210)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Total neoadjuvant therapy for locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Roxburgh, C. S. D.; Strombom, P.; Smith, J. J.; Temple, L. K. F.; Nash, G. M.; Guillem, J. G.; Paty, P.; Garcia-Aguilar, J.; Yaeger, R. D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Updated safety and clinical activity of durvalumab monotherapy in previously treated patients with stage IIIB/IV NSCLC
    Meeting Abstract

    Balmanoukian, A. S.; Antonia, S. J.; Hwu, W. J.; Hamid, O.; Gutierrez, M.; Jamal, R.; Jerusalem, G. H. M.; Ahn, M. J.; Kim, D. W.; Cunningham, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Safety and clinical activity of first-line durvalumab in advanced NSCLC: Updated results from a Phase 1/2 study
    Meeting Abstract

    Antonia, S. J.; Brahmer, J. R.; Balmanoukian, A. S.; Kim, D. W.; Kim, S. W.; Ahn, M. J.; Jamal, R.; Jaeger, D.; Ott, P. A.; Ascierto, P. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Total neoadjuvant chemotherapy to facilitate delivery and tolerance of systemic chemotherapy and response in locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Roxburgh, C. S. D.; Strombom, P.; Smith, J. J.; Temple, L. K. F.; Nash, G. M.; Guillem, J. G.; Paty, P.; Yaeger, R.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of MEK inhibitor - Associated retinopathy: Differences from central serous chorioretinopathy
    Journal Article

    Francis, J. H.; Habib, L. A.; Abramson, D. H.; Yannuzzi, L. A.; Heinemann, M.; Gounder, M. M.; Grisham, R. N.; Postow, M. A.; Shoushtari, A. N.; Chi, P.; more...
    Ophthalmology (2017)

    Fulltext@MSK | Save
  • Induction chemotherapy reduces patient-reported toxicities during neoadjuvant chemoradiation with intensity modulated radiation therapy for rectal cancer
    Meeting Abstract

    Ng, S. Y.; Colborn, K.; Cambridge, L.; Cercek, A.; Reidy, D.; Segal, N.; Stadler, Z.; Saltz, L.; Garcia-Aguilar, J.; Goodman, K. A.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • A blueprint to advance colorectal cancer immunotherapies
    Journal Article

    Le, D. T.; Hubbard-Lucey, V. M.; Morse, M. A.; Heery, C. R.; Dwyer, A.; Marsilje, T. H.; Brodsky, A. N.; Chan, E.; Deming, D. A.; Diaz, L. A. Jr; more...
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • Phase I studies of the novel carcinoembryonic antigen T-cell bispecific (CEA-CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary efficacy and safety in patients (pts) with metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Segal, N. H.; Saro, J.; Melero, I.; Ros, W.; Argiles, G.; Marabelle, A.; Rodriguez Ruiz, M. E.; Albanell, J.; Calvo, E.; Moreno, V.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) and pharmacodynamics (PD) of a novel carcinoembryonic antigen (CEA) T-cell bispecific antibody (CEA-CD3 TCB) for the treatment of CEA-positive solid tumors
    Meeting Abstract

    Melero, I.; Segal, N. H.; Saro, J.; Ros, W.; Martinez-Garcia, M.; Argiles, G.; Moreno, V.; Ponce, S.; Marabelle, A.; Cleary, J. M.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)
    Meeting Abstract

    ArgileĢs, G.; Saro, J.; Segal, N. H.; Melero, I.; Ros, W.; Marabelle, A.; Rodriguez, M. E.; Albanell, J.; Calvo, E.; Moreno, V.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save